13 July 2020

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

13 July 2020 | n=40

  1. Zhou J, Li M, Chen M, Ma Y, et al.
    Near Full-Length Genomic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF106_cpx) Identifified among Heterosexuals in China.
    AIDS Res Hum Retroviruses 2020.

  2. Sessions KJ, Chen YY, Hodge CA, Hudson TR, et al.
    Analysis of CRISPR/Cas9 guide RNA efficiency and specificity against genetically diverse HIV-1 isolates.
    AIDS Res Hum Retroviruses 2020.

  3. Mikasi SG, Isaacs D, Ikomey GM, Shimba H, et al.
    HIV-1 drug resistance mutation analyses of Cameroon derived Integrase sequences.
    AIDS Res Hum Retroviruses 2020.

  4. McManus KAA, Killelea A, Honeycutt E, An Z, et al.
    Assisters Succeed in Insurance Navigation for People Living with HIV and People at Increased Risk of HIV in a Complex Coverage Landscape.
    AIDS Res Hum Retroviruses 2020.

  5. Weichseldorfer M, Affram Y, Heredia A, Tagaya Y, et al.
    Anti-HIV Activity of Standard cART in Primary Cells Is Intensified by CCR5-Targeting Drugs.
    AIDS Res Hum Retroviruses 2020.

  6. Garza J, Moser C, Kitch D, Currier J, et al.
    Impact of Fat Changes on the Effect of Protease Inhibitors on Lumbar Spine Bone Mineral Density Changes with Antiretroviral Therapy (ART) Initiation.
    AIDS Res Hum Retroviruses 2020.

  7. Mehlotra RK.
    New knowledge about CCR5, HIV infection and disease progression: is "old" still valuable?
    AIDS Res Hum Retroviruses 2020.

  8. Sharifi H, Karamouzian M, Khorrami Z, Khalili M, et al.
    Estimation of Coronavirus Disease 2019 Burden and Potential for International Dissemination of Infection From Iran.
    Ann Intern Med 2020;173:73-74.

  9. Brainard D, McCallister S.
    Tenofovir Alafenamide for HIV Preexposure Prophylaxis.
    Ann Intern Med 2020;173:77-78.

  10. Krakower DS, Daskalakis DC, Feinberg J, Marcus JL, et al.
    Tenofovir Alafenamide for HIV Preexposure Prophylaxis.
    Ann Intern Med 2020;173:78.

  11. Deutschmann E, Bucher HC, Jaeckel S, Gibbons S, et al.
    Prevalence of potential drug-drug interactions in patients of the Swiss HIV Cohort Study in the era of HIV integrase inhibitors.
    Clin Infect Dis 2020.

  12. Daley CL, Iaccarino JM, Lange C, Cambau E, et al.
    Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary.
    Clin Infect Dis 2020.

  13. Balmaceda JB, Abd-Elmoniem KZ, Liu CY, Purdy JB, et al.
    Adiponectin Levels Linked to Subclinical Myocardial Fibrosis in HIV.
    J Acquir Immune Defic Syndr 2020.

  14. Rucinski KB, Schwartz SR, Mishra S, Phaswana-Mafuya N, et al.
    High HIV prevalence and low HIV-service engagement among young women who sell sex: A pooled analysis across nine sub-Saharan African countries.
    J Acquir Immune Defic Syndr 2020.

  15. Surial B, Beguelin C, Chave JP, Stockle M, et al.
    Switching from TDF to TAF in HIV/HBV co-infected individuals with renal dysfunction - a prospective cohort study.
    J Acquir Immune Defic Syndr 2020.

  16. Crawford M, van Wyk J, Aboud M, Vannappagari V, et al.
    Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use.
    J Acquir Immune Defic Syndr 2020;83:e2-e5.

  17. Feldacker C, Murenje V, Holeman I, Xaba S, et al.
    Reducing Provider Workload While Preserving Patient Safety: A Randomized Control Trial Using 2-Way Texting for Postoperative Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program.
    J Acquir Immune Defic Syndr 2020;83:16-23.

  18. Overton ET, Kantor A, Fitch KV, Muntner P, et al.
    An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
    J Infect Dis 2020;222:S41-S51.

  19. Umbleja T, Brown TT, Overton ET, Ribaudo HJ, et al.
    Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
    J Infect Dis 2020;222:S52-S62.

  20. Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, et al.
    Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
    J Infect Dis 2020;222:S8-S19.

  21. Grinspoon SK, Douglas PS, Hoffmann U, Ribaudo HJ, et al.
    Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.
    J Infect Dis 2020;222:S1-S7.

  22. Smeaton LM, Kileel EM, Grinsztejn B, Gardner EM, et al.
    Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
    J Infect Dis 2020;222:S31-S40.

  23. Zanni MV, Currier JS, Kantor A, Smeaton L, et al.
    Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
    J Infect Dis 2020;222:S20-S30.

  24. Neilan TG, Nguyen KL, Zaha VG, Chew KW, et al.
    Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
    J Infect Dis 2020;222:S63-S69.

  25. Rich SN, Poschman K, Hu H, Mavian C, et al.
    Sociodemographic, ecological, and spatiotemporal factors associated with HIV drug resistance in Florida: a retrospective analysis.
    J Infect Dis 2020.

  26. Ryom L, Lundgren JD, Reiss P, Ross M, et al.
    The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study.
    J Infect Dis 2020.

  27. Ajaykumar A, Zhu M, Kakkar F, Brophy J, et al.
    Blood mitochondrial DNA levels remain elevated from birth to early life in children HIV-exposed uninfected exposed to combination antiretroviral therapy in utero.
    J Infect Dis 2020.

  28. Franceschini E, De Biasi S, Digaetano M, Bianchini E, et al.
    Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy.
    J Infect Dis 2020.

  29. Pintye J, Huo Y, Kacanek D, Zhang K, et al.
    Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States.
    J Infect Dis 2020.

  30. Dai L, Jung BG, Chen J, Samten B, et al.
    The potential impacts of early secreted antigenic target of 6 kDa (ESAT-6) of Mycobacterium tuberculosis on KSHV-infected cells.
    J Med Virol 2020.

  31. Zhang K, Wei B, Tang Z, Wei Y, et al.
    Acute HIV infection in a large teaching hospital in western China: clinical, virological and molecular epidemiological characteristics.
    J Med Virol 2020.

  32. Masukume G, Mapanga W, Grinberg S, van Zyl DS, et al.
    COVID-19 and HIV co-infection an emerging consensus.
    J Med Virol 2020.

  33. Marimuthu J, Kumar BS, Aravind Gandhi P.
    HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India.
    J Med Virol 2020.

  34. Chaillon A, Nakazawa M, Rawlings SA, Curtin G, et al.
    Subclinical CMV and EBV Shedding is associated with increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    J Virol 2020.

  35. Zhao X, Zheng S, Chen D, Zheng M, et al.
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol 2020.

  36. Zhao W, Akkawi C, Mougel M, Ross SR, et al.
    Murine leukemia virus P50 protein counteracts APOBEC3 by blocking its packaging.
    J Virol 2020.

  37. Kavanagh MM, Katz IT, Holmes CB.
    Reckoning with mortality: global health, HIV, and the politics of data.
    Lancet 2020.

  38. Nazareth J, Minhas JS, Jenkins DR, Sahota A, et al.
    Early lessons from a second COVID-19 lockdown in Leicester, UK.
    Lancet 2020.

  39. Dzau VJ, Fineberg HV, Shine KI, Thier SO, et al.
    A Half-Century of Progress in Health - A Perspective Series in Honor of the 50th Anniversary of the National Academy of Medicine.
    N Engl J Med 2020;383:76-77.

  40. Villabona-Arenas CJ, Hall M, Lythgoe KA, Gaffney SG, et al.
    Number of HIV-1 founder variants is determined by the recency of the source partner infection.
    Science 2020;369:103-108.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

03 August 2020

27 July 2020

20 July 2020

13 July 2020

06 July 2020

13 July 2020

Multidisciplinary Journal Club

  1. Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, et al.
    Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Lancet. 2020;395:1988-1997.

  2. Wolters FJ, Chibnik LB, Waziry R, Anderson R, et al.
    27-year time trends in dementia incidence in Europe and the US: the Alzheimer Cohorts Consortium.
    Neurology. 2020 Jul 1. pii: WNL.0000000000010022.

  3. Bove F, Fraix V, Cavallieri F, Schmitt E, et al.
    Dementia and subthalamic deep brain stimulation in Parkinson disease: A long-term overview.
    Neurology. 2020 Jul 1. pii: WNL.0000000000009822.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016